Unsupervised Physical Activity in Elderly
Safety of an Unsupervised Physical Activity Program and Effects Over Blood Pressure, Physical Fitness and Quality of Life of Elderly Hypertensive Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
To evaluate safety and the effects of a unsupervised physical activity program (USPAP) over blood pressure (BP), physical fitness (PF) and quality of life (QL) of elderly hypertensive patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 14, 2016
CompletedFirst Posted
Study publicly available on registry
November 29, 2016
CompletedNovember 29, 2016
November 1, 2016
2 years
November 14, 2016
November 23, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Lower Blood Pressure and or keeping it under control
12 weeks
Secondary Outcomes (3)
Improve Cardiorespiratory fitness.
12 weeks
Improve abdominal strength.
12 weeks
Quality of life
12 weeks
Study Arms (2)
Unsupervised exercise program
EXPERIMENTALTo verify the interference of an unsupervised exercise program on blood pressure, physical fitness, quality of life and safety in elderly hypertensive patients. Participants were divided into the study group or control group
Physical fitness and quality of life
EXPERIMENTALTo verify the interference of a walking program on physical fitness and quality of life.
Interventions
Both control and intervention group undergo clinical evaluation, and anthropometric measurements, blood pressure (casual and ambulatory blood pressure monitoring), physical and laboratorial tests, and the assesment of Quality of Life by Questionnaire SF-36 were done at the beginning and the end of the study.After a period of 12 weeks of unsupervised walking program in which participants were asked to do it three times a week at least, at a moderate intensity (40 to \< 60% of heart rate reserve), all participants underwent a complete re-evaluation to compare the results obtained with the proposed program. Data were analyzed using SPPS, v.23.0.
Both control and intervention group undergo clinical evaluation, and anthropometric measurements, blood pressure (casual and ambulatory blood pressure monitoring), physical and laboratorial tests, and the assesment of Quality of Life by Questionnaire SF-36 were done at the beginning and the end of the study.After a period of 12 weeks of unsupervised walking program in which participants were asked to do it three times a week at least, at a moderate intensity (40 to \< 60% of heart rate reserve), all participants underwent a complete re-evaluation to compare the results obtained with the proposed program. Data were analyzed using SPPS, v.23.0.
Eligibility Criteria
You may qualify if:
- years old or more, stable BP on the last three months, no changes on pharmacological treatment over the last six months and a sedentary behavior (non-participation in any kind of physical activity for at least 2 months).
You may not qualify if:
- uncontrolled diabetes
- congestive heart failure
- acute myocardial infarction in the last six months
- stroke in the last six months or under rehabilitation
- previously diagnosed chronic renal failure
- acute infectious diseases
- recent systemic or pulmonary embolism
- pulmonary hypertension
- BP higher than 159 x 99 mmHg
- neuromuscular
- musculoskeletal or articular disorders diagnosed and not treated
- clinical evaluation restraining PA
- any situation preventing the patient from walk. Those criteria were verified in patients' medical charts.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hypertension League
Goiânia, Goiás, 74000, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 14, 2016
First Posted
November 29, 2016
Study Start
March 1, 2014
Primary Completion
March 1, 2016
Study Completion
May 1, 2016
Last Updated
November 29, 2016
Record last verified: 2016-11